1-4 of 4
Arabella Mazzocchi
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Early Reduction of Serum TARC Levels Predicts Prognosis of Patients Treated with a PET-Adapted Strategy for Advanced Stage Hodgkin Lymphoma (HL) in the GITIL/FIL HD0607 Trial

Simonetta Viviani, MD, Arabella Mazzocchi, PhD, Chiara Pavoni, Statistician, Francesca Taverna, Anna Guidetti, MD, Andrea Rossi, MD, Caterina Patti, MD, Alessandra Romano, MDPhD, Livio Trentin, MD, Davide Rapezzi, MD, Daniela Gottardi, MD, Corrado Tarella, MD, Michele Cimminiello, MD PhD, Roberta Zanotti, MD, Andrés J M Ferreri, MD, Roberta Serpi, Paolo Corradini, MD, Alessandro M. Gianni, MDProf, Andrea Gallamini, MD, Alessandro Rambaldi, MD Prof
Journal: Blood
Blood (2017) 130 (Supplement 1): 1511.
https://doi.org/10.1182/blood.V130.Suppl_1.1511.1511
Published: 2017
Journal Articles

TARC before ASCT Is Highly Predictive of Outcome in Patients with Relapsed or Refractory (R/R) Classical Hodgkin Lymphoma (cHL) after First-Line Therapy

Simonetta Viviani, MD, Francesco Spina, MD, Arabella Mazzocchi, Maria Galbiati, Flavio Crippa, MD, Lucia Farina, MD PhD, Anna Guidetti, MD, Massimo Di Nicola, Liliana Franca Devizzi, MD, Paola Matteucci, MD, Michele Magni, MD, Anna Dodero, Alessandro M. Gianni, MD, Paolo Corradini, MD
Journal: Blood
Blood (2016) 128 (22): 3009.
https://doi.org/10.1182/blood.V128.22.3009.3009
Published: 2016
Journal Articles

Decrease of Serum TARC Levels As Predictive Biomarkers of Response to Targeted Therapy with Kinase Inhibitors in Refractory/Relapsed Hodgkin Lymphoma Patients

Anna Guidetti, MD, Simonetta Viviani, MD, Anna Dodero, MD, Lucia Farina, MD, Domenico Russo, MD PhD, Pietro Bulian, Massimo Di Nicola, MD, Arabella Mazzocchi, MD, Fernando Ravagnani, MD, Paolo Corradini, MD, Alessandro Massimo Gianni, MD, Carmelo Carlo-Stella, MD
Journal: Blood
Blood (2014) 124 (21): 4459.
https://doi.org/10.1182/blood.V124.21.4459.4459
Published: 2014
Journal Articles

TARC Is Useful as Additional Prognostic Factor for Hodgkin's Lymphoma Outcome.

Simonetta Viviani, MD, Arabella Mazzocchi, Valeria Bonfante, Rosalba Miceli, MD, Davide Dalu, MD, Marina Galbiati, Fernando Ravagnani, Luigi Mariani, Alessandro Massimo Gianni
Journal: Blood
Blood (2009) 114 (22): 1557.
https://doi.org/10.1182/blood.V114.22.1557.1557
Published: 2009